In another study conducted in the USA, which also included patients with diabetes, hypertension and dyslipidemia, nonadherence rates were similar to those reported by Lopez‐Simarro et al.13: 43% for metformin, 23% for ACE inhibitors and 36% for statins.25 The gene discussed is ACE; the disease is metabolic syndrome.